In contrast, deletion of NLRP3 reverses the symptoms in mouse models of obese asthma,42 suggesting targeting NLRP3 inflammasome has important potential in obesity‐associated airway allergic diseases. Here, NLRP3 is linked to obesity due to melanocortin 4 receptor deficiency.